Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
Xiwen QinJoseph HungTiew-Hwa Katherine TengTom BriffaFrank M SanfilippoPublished in: Journal of cardiovascular pharmacology and therapeutics (2020)
Among seniors hospitalized for HF, discontinuation gaps were common for RASI and β-blockers postdischarge, and long-term adherence to these medications was suboptimal. Where appropriate, strategies to improve long-term medication adherence are indicated in HF patients, particularly in elderly patients with comorbidities.